Researchers are exploring the metabolic vulnerabilities of diffuse large B-cell lymphoma, a type of blood cancer, to identify potential therapeutic opportunities. Studies are investigating various aspects of tumor metabolism, including reprogramming, adaptation, and the metabolic-immune axis, to better understand the disease and develop new treatments. The research encompasses related areas, such as lipid metabolism and nuclear metabolism, in pursuit of precision therapy strategies.